Publicado: 19/04/2021

J&J Covid vaccine manufacturing halted at plant that ruined doses

J&J Covid vaccine manufacturing halted at plant that ruined doses

Washington (AFP) -

The US Food and Drug Administration requested that production of the Johnson & Johnson coronavirus vaccine be halted at a factory that previously reportedly ruined about 15 million doses of the shot.

The pharmaceutical giant told AFP at the end of March it had identified a batch of doses at a plant in Baltimore run by Emergent BioSolutions 'that did not meet quality standards,' but did not confirm the specific number affected.

The New York Times later reported the batch consisted of about 15 million doses.

Emergent BioSolutions said in a regulatory Securities and Exchange Commission filing on Monday that the FDA had requested a pause on April 16 in production of the single-shot vaccine pending an inspection at the Baltimore, Maryland facility.

'On April 16, 2021, at the request of the FDA, Emergent agreed not to initiate the manufacturing of any new material at its Bayview facility and to quarantine existing material manufactured at the Bayview facility pending completion of the inspection and remediation of any resulting findings,' the filing said.

Johnson & Johnson had said in March it was sending more experts to the site to oversee vaccine production, and that it expected to deliver 24 million additional shots through April.

The Emergent BioSolutions plant had not been authorized by US regulators at the time to manufacture a 'drug substance' for the J&J vaccine, the pharmaceutical company said, but US media reported that it was expected to produce tens of millions of doses in the near future.

The J&J vaccine won praise for its single dosage and because it does not need to be frozen -- unlike the shots from Moderna and Pfizer -- making distribution much simpler.

The manufacturing pause is the latest setback for the vaccine in the United States, as regulators temporarily halted its use after authorities reported six cases of women developing blood clots along with low blood platelet counts, including one death, within two weeks of getting the J&J shot.

Europe's medicines regulator is expected to rule Tuesday on the J&J vaccine's safety, after its European use was also put on hold over blood clot fears.

Más en Zeta

Nada de perros

Nada de perros

07 May 2021
Un fiscal dijo que en las investigaciones que realizaron sobre los albergues, no se encontró evidencia sobre comida de perros para los niños. Varias diputadas habían hecho la afirmación. Ahora queda la duda. Perjudicando a la genteLos taxistas que cerraron varias vías en Panamá, Panamá Oeste y P...

Prohibir las armas de asalto en EE.UU.

ZETA, (AMY GOODMAN-DENIS MOYNIHAN).- Las masacres ocurridas recientemente en la ciudad de Boulder, en Colorado, y en el área metropolitana de la ciudad de Atlanta, en Georgia, con un saldo de diez y ocho muertos, respectivamente, son solo dos casos más de la violencia sin sentido con armas de fue...

La justicia no tiene espacios para más desatinos

ZETA, (JEAN PIERRE LEIGNADIER*).-Las próximas dos semanas, este espacio abordará dos deficiencias estructurales que la Cámara de Comercio, Industrias y Agricultura de Panamá (CCIAP) ha planteado por más de dos quinquenios e insistimos deben ser atendidas de manera urgente para enrumbar nuestro de...

Libertad económica y libre empresa

ZETA, (JEAN PIERRE LEIGNADIER*).- Desde su fundación hace 105 años, la Cámara de Comercio, Industrias y Agricultura de Panamá ha tenido como unos de sus pilares la defensa de la libertad económica y la libre empresa como factores indispensables para el progreso sostenido y sostenible del país. E...

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.